Retinal dystrophies are a heterogeneous group of diseases in which the retina degenerates, leading to either partial or complete blindness. The severe and clearly hereditary forms, retinitis ...

PYC Therapeutics advances VP-001 for retinitis pigmentosa, gaining FDA insights for its upcoming registrational trial.

Through the program, gene therapies are developed to treat patients with retinitis pigmentosa caused by pathogenic variants ...

In addition, three specific mutations of the rhodopsin ( RHO) gene, which typically causes autosomal dominant-retinitis pigmentosa (see section on rod-cone dystrophies), have been associated with ...

Lipoprotein(a) is thought to contribute to ASCVD through proinflammatory, prothrombotic, and/or other proatherogenic mechanisms. 3, 9 Current evidence suggests that lipoprotein(a) is causal in the ...